Email
Print
Anti-Inflammatory Therapeutics Market - Forecast(2024 - 2030)
1. Anti-Inflammatory Therapeutics Market - Overview
1.1 Definitions and Scope
2. Anti-Inflammatory Therapeutics Market - Executive summary
2.1 Market Revenue, Market Size and Key Trends by Company
2.2 Key Trends by type of Application
2.3 Key Trends segmented by Geography
3. Anti-Inflammatory Therapeutics Market
3.1 Comparative analysis
3.1.1 Product Benchmarking - Top 10 companies
3.1.2 Top 5 Financials Analysis
3.1.3 Market Value split by Top 10 companies
3.1.4 Patent Analysis - Top 10 companies
3.1.5 Pricing Analysis
4. Anti-Inflammatory Therapeutics Market - Startup companies Scenario Premium
4.1 Top 10 startup company Analysis by
4.1.1 Investment
4.1.2 Revenue
4.1.3 Market Shares
4.1.4 Market Size and Application Analysis
4.1.5 Venture Capital and Funding Scenario
5. Anti-Inflammatory Therapeutics Market - Industry Market Entry Scenario Premium
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis - Top 10 companies
6. Anti-Inflammatory Therapeutics Market Forces
6.1 Drivers
6.2 Constraints
6.3 Challenges
6.4 Porters five force model
6.4.1 Bargaining power of suppliers
6.4.2 Bargaining powers of customers
6.4.3 Threat of new entrants
6.4.4 Rivalry among existing players
6.4.5 Threat of substitutes
7. Anti-Inflammatory Therapeutics Market -Strategic analysis
7.1 Value chain analysis
7.2 Opportunities analysis
7.3 Product life cycle
7.4 Suppliers and distributors Market Share
8. Anti-Inflammatory Therapeutics Market - By Product Type (Market Size -$Million / $Billion)
8.1 Market Size and Market Share Analysis
8.2 Application Revenue and Trend Research
8.3 Product Segment Analysis
9. Anti-Inflammatory Therapeutics Market - By Indication (Market Size -$Million / $Billion)
9.1 Arthritis
9.1.1 Rheumatoid Arthritis
9.1.2 Osteoarthritis
9.1.3 Ankylosing Spondylitis
9.1.4 Psoriatic Arthritis
9.1.5 Gout
9.2 Respiratory Disease
9.2.1 Asthma
9.2.2 Chronic Obstructive Pulmonary Disease
9.3 Multiple Sclerosis
9.4 Psoriasis
9.5 Inflammatory Bowel Disease
9.5.1 Crohn Disease
9.5.2 Ulcerative Colitis
9.6 Other Inflammatory Disease
10. Anti-Inflammatory Therapeutics - By Drug Class (Market Size -$Million / $Billion)
10.1 Segment type Size and Market Share Analysis
10.2 Application Revenue and Trends by type of Application
10.3 Application Segment Analysis by Type
10.3.1 Anti-Inflammatory Biologics
10.3.2 Nonsteroidal Anti-Inflammatory Drug
10.3.3 Corticosteroid
10.3.4 Other Anti-Inflammatory Drug
11. Anti-Inflammatory Therapeutics- By Geography (Market Size -$Million / $Billion)
11.1 Anti-Inflammatory Therapeutics Market - North America Segment Research
11.2 North America Market Research (Million / $Billion)
11.2.1 Segment type Size and Market Size Analysis
11.2.2 Revenue and Trends
11.2.3 Application Revenue and Trends by type of Application
11.2.4 Company Revenue and Product Analysis
11.2.5 North America Product type and Application Market Size
11.2.5.1 U.S
11.2.5.2 Canada
11.2.5.3 Mexico
11.2.5.4 Rest of North America
11.3 Anti-Inflammatory Therapeutics- South America Segment Research
11.4 South America Market Research (Market Size -$Million / $Billion)
11.4.1 Segment type Size and Market Size Analysis
11.4.2 Revenue and Trends
11.4.3 Application Revenue and Trends by type of Application
11.4.4 Company Revenue and Product Analysis
11.4.5 South America Product type and Application Market Size
11.4.5.1 Brazil
11.4.5.2 Venezuela
11.4.5.3 Argentina
11.4.5.4 Ecuador
11.4.5.5 Peru
11.4.5.6 Colombia
11.4.5.7 Costa Rica
11.4.5.8 Rest of South America
11.5 Anti-Inflammatory Therapeutics- Europe Segment Research
11.6 Europe Market Research (Market Size -$Million / $Billion)
11.6.1 Segment type Size and Market Size Analysis
11.6.2 Revenue and Trends
11.6.3 Application Revenue and Trends by type of Application
11.6.4 Company Revenue and Product Analysis
11.6.5 Europe Segment Product type and Application Market Size
11.6.5.1 U.K
11.6.5.2 Germany
11.6.5.3 Italy
11.6.5.4 France
11.6.5.5 Netherlands
11.6.5.6 Belgium
11.6.5.7 Denmark
11.6.5.8 Spain
11.6.5.9 Rest of Europe
11.7 Anti-Inflammatory Therapeutics - APAC Segment Research
11.8 APAC Market Research (Market Size -$Million / $Billion)
11.8.1 Segment type Size and Market Size Analysis
11.8.2 Revenue and Trends
11.8.3 Application Revenue and Trends by type of Application
11.8.4 Company Revenue and Product Analysis
11.8.5 APAC Segment - Product type and Application Market Size
11.8.5.1 China
11.8.5.2 Australia
11.8.5.3 Japan
11.8.5.4 South Korea
11.8.5.5 India
11.8.5.6 Taiwan
11.8.5.7 Malaysia
11.8.5.8 Hong kong
11.8.5.9 Rest of APAC
11.9 Anti-Inflammatory Therapeutics - Middle East Segment and Africa Segment Research
11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
11.10.1 Segment type Size and Market Size Analysis
11.10.2 Revenue and Trend Analysis
11.10.3 Application Revenue and Trends by type of Application
11.10.4 Company Revenue and Product Analysis
11.10.5 Middle East Segment Product type and Application Market Size
11.10.5.1 Israel
11.10.5.2 Saudi Arabia
11.10.5.3 UAE
11.10.6 Africa Segment Analysis
11.10.6.1 South Africa
11.10.6.2 Rest of Middle East & Africa
12. Anti-Inflammatory Therapeutics Market - Entropy
12.1 New product launches
12.2 M&A s, collaborations, JVs and partnerships
13. Anti-Inflammatory Therapeutics Market - Industry / Segment Competition landscape Premium
13.1 Market Share Analysis
13.1.1 Market Share by Country- Top companies
13.1.2 Market Share by Region- Top 10 companies
13.1.3 Market Share by type of Application - Top 10 companies
13.1.4 Market Share by type of Product / Product category- Top 10 companies
13.1.5 Market Share at global level - Top 10 companies
13.1.6 Best Practises for companies
14. Anti-Inflammatory Therapeutics Market - Key Company List by Country Premium
15. Anti-Inflammatory Therapeutics Market Company Analysis
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Abbvie Inc
15.3 Amgen Inc
15.4 Astrazeneca Plc
15.5 Eli Lily And Company
15.6 F. Hoffmann-La Roche Ag
15.7 Glaxosmithkline Plc
15.8 Johnson Johnson
15.9 Merck Co , Inc
15.10 Novartis Ag
15.11 Pfizer Inc
15.12 Company 11
15.13 Company 12 & More
*Financials would be provided on a best efforts basis for private companies
16. Anti-Inflammatory Therapeutics Market - Appendix
16.1 Abbreviations
16.2 Sources
17. Anti-Inflammatory Therapeutics Market - Methodology
17.1 Research Methodology
17.1.1 Company Expert Interviews
17.1.2 Industry Databases
17.1.3 Associations
17.1.4 Company News
17.1.5 Company Annual Reports
17.1.6 Application Trends
17.1.7 New Products and Product database
17.1.8 Company Transcripts
17.1.9 R&D Trends
17.1.10 Key Opinion Leaders Interviews
17.1.11 Supply and Demand Trends
LIST OF TABLES
1.Global By Indication Market 2023-2030 ($M)1.1 Arthritis Market 2023-2030 ($M) - Global Industry Research
1.1.1 Rheumatoid Arthritis Market 2023-2030 ($M)
1.1.2 Osteoarthritis Market 2023-2030 ($M)
1.1.3 Ankylosing Spondylitis Market 2023-2030 ($M)
1.1.4 Psoriatic Arthritis Market 2023-2030 ($M)
1.1.5 Gout Market 2023-2030 ($M)
1.2 Respiratory Disease Market 2023-2030 ($M) - Global Industry Research
1.2.1 Asthma Market 2023-2030 ($M)
1.2.2 Chronic Obstructive Pulmonary Disease Market 2023-2030 ($M)
1.3 Multiple Sclerosis Market 2023-2030 ($M) - Global Industry Research
1.4 Psoriasis Market 2023-2030 ($M) - Global Industry Research
1.5 Inflammatory Bowel Disease Market 2023-2030 ($M) - Global Industry Research
1.5.1 Crohn Disease Market 2023-2030 ($M)
1.5.2 Ulcerative Colitis Market 2023-2030 ($M)
2.Global By Drug Class Market 2023-2030 ($M)
2.1 Anti-Inflammatory Biologics Market 2023-2030 ($M) - Global Industry Research
2.1.1 Key Market Trend Market 2023-2030 ($M)
2.1.2 Market Market 2023-2030 ($M)
2.2 Nonsteroidal Anti-Inflammatory Drug Market 2023-2030 ($M) - Global Industry Research
2.2.1 Market Growth Factor And Opportunity Market 2023-2030 ($M)
2.3 Corticosteroid Market 2023-2030 ($M) - Global Industry Research
3.Global By Indication Market 2023-2030 (Volume/Units)
3.1 Arthritis Market 2023-2030 (Volume/Units) - Global Industry Research
3.1.1 Rheumatoid Arthritis Market 2023-2030 (Volume/Units)
3.1.2 Osteoarthritis Market 2023-2030 (Volume/Units)
3.1.3 Ankylosing Spondylitis Market 2023-2030 (Volume/Units)
3.1.4 Psoriatic Arthritis Market 2023-2030 (Volume/Units)
3.1.5 Gout Market 2023-2030 (Volume/Units)
3.2 Respiratory Disease Market 2023-2030 (Volume/Units) - Global Industry Research
3.2.1 Asthma Market 2023-2030 (Volume/Units)
3.2.2 Chronic Obstructive Pulmonary Disease Market 2023-2030 (Volume/Units)
3.3 Multiple Sclerosis Market 2023-2030 (Volume/Units) - Global Industry Research
3.4 Psoriasis Market 2023-2030 (Volume/Units) - Global Industry Research
3.5 Inflammatory Bowel Disease Market 2023-2030 (Volume/Units) - Global Industry Research
3.5.1 Crohn Disease Market 2023-2030 (Volume/Units)
3.5.2 Ulcerative Colitis Market 2023-2030 (Volume/Units)
4.Global By Drug Class Market 2023-2030 (Volume/Units)
4.1 Anti-Inflammatory Biologics Market 2023-2030 (Volume/Units) - Global Industry Research
4.1.1 Key Market Trend Market 2023-2030 (Volume/Units)
4.1.2 Market Market 2023-2030 (Volume/Units)
4.2 Nonsteroidal Anti-Inflammatory Drug Market 2023-2030 (Volume/Units) - Global Industry Research
4.2.1 Market Growth Factor And Opportunity Market 2023-2030 (Volume/Units)
4.3 Corticosteroid Market 2023-2030 (Volume/Units) - Global Industry Research
5.North America By Indication Market 2023-2030 ($M)
5.1 Arthritis Market 2023-2030 ($M) - Regional Industry Research
5.1.1 Rheumatoid Arthritis Market 2023-2030 ($M)
5.1.2 Osteoarthritis Market 2023-2030 ($M)
5.1.3 Ankylosing Spondylitis Market 2023-2030 ($M)
5.1.4 Psoriatic Arthritis Market 2023-2030 ($M)
5.1.5 Gout Market 2023-2030 ($M)
5.2 Respiratory Disease Market 2023-2030 ($M) - Regional Industry Research
5.2.1 Asthma Market 2023-2030 ($M)
5.2.2 Chronic Obstructive Pulmonary Disease Market 2023-2030 ($M)
5.3 Multiple Sclerosis Market 2023-2030 ($M) - Regional Industry Research
5.4 Psoriasis Market 2023-2030 ($M) - Regional Industry Research
5.5 Inflammatory Bowel Disease Market 2023-2030 ($M) - Regional Industry Research
5.5.1 Crohn Disease Market 2023-2030 ($M)
5.5.2 Ulcerative Colitis Market 2023-2030 ($M)
6.North America By Drug Class Market 2023-2030 ($M)
6.1 Anti-Inflammatory Biologics Market 2023-2030 ($M) - Regional Industry Research
6.1.1 Key Market Trend Market 2023-2030 ($M)
6.1.2 Market Market 2023-2030 ($M)
6.2 Nonsteroidal Anti-Inflammatory Drug Market 2023-2030 ($M) - Regional Industry Research
6.2.1 Market Growth Factor And Opportunity Market 2023-2030 ($M)
6.3 Corticosteroid Market 2023-2030 ($M) - Regional Industry Research
7.South America By Indication Market 2023-2030 ($M)
7.1 Arthritis Market 2023-2030 ($M) - Regional Industry Research
7.1.1 Rheumatoid Arthritis Market 2023-2030 ($M)
7.1.2 Osteoarthritis Market 2023-2030 ($M)
7.1.3 Ankylosing Spondylitis Market 2023-2030 ($M)
7.1.4 Psoriatic Arthritis Market 2023-2030 ($M)
7.1.5 Gout Market 2023-2030 ($M)
7.2 Respiratory Disease Market 2023-2030 ($M) - Regional Industry Research
7.2.1 Asthma Market 2023-2030 ($M)
7.2.2 Chronic Obstructive Pulmonary Disease Market 2023-2030 ($M)
7.3 Multiple Sclerosis Market 2023-2030 ($M) - Regional Industry Research
7.4 Psoriasis Market 2023-2030 ($M) - Regional Industry Research
7.5 Inflammatory Bowel Disease Market 2023-2030 ($M) - Regional Industry Research
7.5.1 Crohn Disease Market 2023-2030 ($M)
7.5.2 Ulcerative Colitis Market 2023-2030 ($M)
8.South America By Drug Class Market 2023-2030 ($M)
8.1 Anti-Inflammatory Biologics Market 2023-2030 ($M) - Regional Industry Research
8.1.1 Key Market Trend Market 2023-2030 ($M)
8.1.2 Market Market 2023-2030 ($M)
8.2 Nonsteroidal Anti-Inflammatory Drug Market 2023-2030 ($M) - Regional Industry Research
8.2.1 Market Growth Factor And Opportunity Market 2023-2030 ($M)
8.3 Corticosteroid Market 2023-2030 ($M) - Regional Industry Research
9.Europe By Indication Market 2023-2030 ($M)
9.1 Arthritis Market 2023-2030 ($M) - Regional Industry Research
9.1.1 Rheumatoid Arthritis Market 2023-2030 ($M)
9.1.2 Osteoarthritis Market 2023-2030 ($M)
9.1.3 Ankylosing Spondylitis Market 2023-2030 ($M)
9.1.4 Psoriatic Arthritis Market 2023-2030 ($M)
9.1.5 Gout Market 2023-2030 ($M)
9.2 Respiratory Disease Market 2023-2030 ($M) - Regional Industry Research
9.2.1 Asthma Market 2023-2030 ($M)
9.2.2 Chronic Obstructive Pulmonary Disease Market 2023-2030 ($M)
9.3 Multiple Sclerosis Market 2023-2030 ($M) - Regional Industry Research
9.4 Psoriasis Market 2023-2030 ($M) - Regional Industry Research
9.5 Inflammatory Bowel Disease Market 2023-2030 ($M) - Regional Industry Research
9.5.1 Crohn Disease Market 2023-2030 ($M)
9.5.2 Ulcerative Colitis Market 2023-2030 ($M)
10.Europe By Drug Class Market 2023-2030 ($M)
10.1 Anti-Inflammatory Biologics Market 2023-2030 ($M) - Regional Industry Research
10.1.1 Key Market Trend Market 2023-2030 ($M)
10.1.2 Market Market 2023-2030 ($M)
10.2 Nonsteroidal Anti-Inflammatory Drug Market 2023-2030 ($M) - Regional Industry Research
10.2.1 Market Growth Factor And Opportunity Market 2023-2030 ($M)
10.3 Corticosteroid Market 2023-2030 ($M) - Regional Industry Research
11.APAC By Indication Market 2023-2030 ($M)
11.1 Arthritis Market 2023-2030 ($M) - Regional Industry Research
11.1.1 Rheumatoid Arthritis Market 2023-2030 ($M)
11.1.2 Osteoarthritis Market 2023-2030 ($M)
11.1.3 Ankylosing Spondylitis Market 2023-2030 ($M)
11.1.4 Psoriatic Arthritis Market 2023-2030 ($M)
11.1.5 Gout Market 2023-2030 ($M)
11.2 Respiratory Disease Market 2023-2030 ($M) - Regional Industry Research
11.2.1 Asthma Market 2023-2030 ($M)
11.2.2 Chronic Obstructive Pulmonary Disease Market 2023-2030 ($M)
11.3 Multiple Sclerosis Market 2023-2030 ($M) - Regional Industry Research
11.4 Psoriasis Market 2023-2030 ($M) - Regional Industry Research
11.5 Inflammatory Bowel Disease Market 2023-2030 ($M) - Regional Industry Research
11.5.1 Crohn Disease Market 2023-2030 ($M)
11.5.2 Ulcerative Colitis Market 2023-2030 ($M)
12.APAC By Drug Class Market 2023-2030 ($M)
12.1 Anti-Inflammatory Biologics Market 2023-2030 ($M) - Regional Industry Research
12.1.1 Key Market Trend Market 2023-2030 ($M)
12.1.2 Market Market 2023-2030 ($M)
12.2 Nonsteroidal Anti-Inflammatory Drug Market 2023-2030 ($M) - Regional Industry Research
12.2.1 Market Growth Factor And Opportunity Market 2023-2030 ($M)
12.3 Corticosteroid Market 2023-2030 ($M) - Regional Industry Research
13.MENA By Indication Market 2023-2030 ($M)
13.1 Arthritis Market 2023-2030 ($M) - Regional Industry Research
13.1.1 Rheumatoid Arthritis Market 2023-2030 ($M)
13.1.2 Osteoarthritis Market 2023-2030 ($M)
13.1.3 Ankylosing Spondylitis Market 2023-2030 ($M)
13.1.4 Psoriatic Arthritis Market 2023-2030 ($M)
13.1.5 Gout Market 2023-2030 ($M)
13.2 Respiratory Disease Market 2023-2030 ($M) - Regional Industry Research
13.2.1 Asthma Market 2023-2030 ($M)
13.2.2 Chronic Obstructive Pulmonary Disease Market 2023-2030 ($M)
13.3 Multiple Sclerosis Market 2023-2030 ($M) - Regional Industry Research
13.4 Psoriasis Market 2023-2030 ($M) - Regional Industry Research
13.5 Inflammatory Bowel Disease Market 2023-2030 ($M) - Regional Industry Research
13.5.1 Crohn Disease Market 2023-2030 ($M)
13.5.2 Ulcerative Colitis Market 2023-2030 ($M)
14.MENA By Drug Class Market 2023-2030 ($M)
14.1 Anti-Inflammatory Biologics Market 2023-2030 ($M) - Regional Industry Research
14.1.1 Key Market Trend Market 2023-2030 ($M)
14.1.2 Market Market 2023-2030 ($M)
14.2 Nonsteroidal Anti-Inflammatory Drug Market 2023-2030 ($M) - Regional Industry Research
14.2.1 Market Growth Factor And Opportunity Market 2023-2030 ($M)
14.3 Corticosteroid Market 2023-2030 ($M) - Regional Industry Research
LIST OF FIGURES
1.US Asia-Pacific Anti-Inflammatory Therapeutics Market Revenue, 2023-2030 ($M)2.Canada Asia-Pacific Anti-Inflammatory Therapeutics Market Revenue, 2023-2030 ($M)
3.Mexico Asia-Pacific Anti-Inflammatory Therapeutics Market Revenue, 2023-2030 ($M)
4.Brazil Asia-Pacific Anti-Inflammatory Therapeutics Market Revenue, 2023-2030 ($M)
5.Argentina Asia-Pacific Anti-Inflammatory Therapeutics Market Revenue, 2023-2030 ($M)
6.Peru Asia-Pacific Anti-Inflammatory Therapeutics Market Revenue, 2023-2030 ($M)
7.Colombia Asia-Pacific Anti-Inflammatory Therapeutics Market Revenue, 2023-2030 ($M)
8.Chile Asia-Pacific Anti-Inflammatory Therapeutics Market Revenue, 2023-2030 ($M)
9.Rest of South America Asia-Pacific Anti-Inflammatory Therapeutics Market Revenue, 2023-2030 ($M)
10.UK Asia-Pacific Anti-Inflammatory Therapeutics Market Revenue, 2023-2030 ($M)
11.Germany Asia-Pacific Anti-Inflammatory Therapeutics Market Revenue, 2023-2030 ($M)
12.France Asia-Pacific Anti-Inflammatory Therapeutics Market Revenue, 2023-2030 ($M)
13.Italy Asia-Pacific Anti-Inflammatory Therapeutics Market Revenue, 2023-2030 ($M)
14.Spain Asia-Pacific Anti-Inflammatory Therapeutics Market Revenue, 2023-2030 ($M)
15.Rest of Europe Asia-Pacific Anti-Inflammatory Therapeutics Market Revenue, 2023-2030 ($M)
16.China Asia-Pacific Anti-Inflammatory Therapeutics Market Revenue, 2023-2030 ($M)
17.India Asia-Pacific Anti-Inflammatory Therapeutics Market Revenue, 2023-2030 ($M)
18.Japan Asia-Pacific Anti-Inflammatory Therapeutics Market Revenue, 2023-2030 ($M)
19.South Korea Asia-Pacific Anti-Inflammatory Therapeutics Market Revenue, 2023-2030 ($M)
20.South Africa Asia-Pacific Anti-Inflammatory Therapeutics Market Revenue, 2023-2030 ($M)
21.North America Asia-Pacific Anti-Inflammatory Therapeutics By Application
22.South America Asia-Pacific Anti-Inflammatory Therapeutics By Application
23.Europe Asia-Pacific Anti-Inflammatory Therapeutics By Application
24.APAC Asia-Pacific Anti-Inflammatory Therapeutics By Application
25.MENA Asia-Pacific Anti-Inflammatory Therapeutics By Application
26.Pfizer Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Abbvie Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Johnson Johnson, Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Glaxosmithkline Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Merck Co , Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Novartis Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
32.F. Hoffmann-La Roche Ag, Sales /Revenue, 2015-2018 ($Mn/$Bn)
33.Eli Lily And Company, Sales /Revenue, 2015-2018 ($Mn/$Bn)
34.Astrazeneca Plc, Sales /Revenue, 2015-2018 ($Mn/$Bn)
35.Amgen Inc, Sales /Revenue, 2015-2018 ($Mn/$Bn)